Louisiana Medical Marijuana Program

Last verified: April 2026

Louisiana's Medical Cannabis Program — A Twelve-Year Build

Louisiana technically had a medical marijuana law on the books in 1978 — one of the first in the country — but it was a dormant statute that never produced a functioning program. For nearly four decades it sat unused. The modern program emerged from a series of legislative actions starting in 2015 and continuing through 2022.

The Statutory Architecture

The medical program is codified primarily at LRS §40:1046 (the Therapeutic Marijuana statute), with implementing rules from three agencies:

• Louisiana Department of Health (LDH) — patient-program administration; qualifying-condition rule-making.
• Louisiana Board of Pharmacy — Marijuana Pharmacy licensing and inspection.
• Louisiana Department of Agriculture and Forestry (LDAF) — production-license oversight (LSU and Southern).

The Two Universities — Act 261 of 2015

Act 261 of 2015 designated the LSU AgCenter and the Southern University Agricultural Research and Extension Center as the only two entities that could license cannabis production in Louisiana.

• LSU's partner: Wellcana Group LLC (2017) → acquired by Good Day Farm Louisiana.
• Southern's partner: Ilera Holistic Healthcare.

See full producer page.

The Ten Marijuana Pharmacies

The program is capped at 10 active Marijuana Pharmacy licenses statewide, allocated one per LDH administrative region. Each license must be held by, and operationally controlled by, a Louisiana-licensed pharmacist (the "pharmacist-in-charge").

Smokable Flower — Authorized Since January 1, 2022

House Bill 819 of 2020 was the most consequential legislative shift since 2015. It authorized raw, smokable cannabis flower to be sold by Louisiana marijuana pharmacies, with the change taking commercial effect on January 1, 2022. The first legal flower sales in Louisiana history occurred at Capitol Wellness Solutions in Baton Rouge in early January 2022. See full flower-authorization story.

Act 424 (2021) — "Any Debilitating Condition"

Act 424 of 2021 is one of the most unusual qualifying-condition provisions in U.S. medical cannabis law. It amended LRS §40:1046 so that a Louisiana-licensed physician may recommend medical cannabis for "any condition a physician, in his medical opinion, considers debilitating to an individual patient." In effect, Louisiana converted from a strict closed-list state to an open-ended physician-discretion model — while keeping the supply side rigidly closed. See qualifying conditions.

How a Patient Visit Works

A Louisiana medical patient does not "shop a menu" the way a Colorado adult-use buyer does. The legal architecture treats every visit as a pharmacy interaction:

1. The patient must hold a physician recommendation (not technically a "prescription," because cannabis remains federally Schedule I).
2. The patient registers with the pharmacy.
3. A licensed pharmacist or pharmacy technician performs the dispense, with the pharmacist-in-charge legally responsible.
4. The transaction is logged through the state's prescription-monitoring infrastructure adapted for cannabis.
5. Counseling on dosing, drug interactions, and onset times is part of the dispense — and is genuinely delivered.

See full enrollment guide.

Patient Counts

⚠️ Louisiana's active medical-patient count climbed steadily after the Act 424 expansion and the 2022 introduction of flower. Recent state reporting puts active patients in the range of approximately 50,000 to 60,000, but counts vary depending on whether "registered patients" or "patients with active recommendations" is being measured. Verify with LDH.

The 7% Sales Tax

Medical cannabis carries a 7% state sales tax — a politically negotiated middle ground when HB 819 was passed. The tax is collected at the pharmacy and remitted to the state; revenue is dedicated in part to the program's regulatory costs. Local sales taxes generally do not stack on medical cannabis, though this is occasionally litigated.

What Is NOT Allowed

• No home cultivation. Growing any amount remains a manufacture offense under LRS §40:966(A).
• No delivery in most cases (limited exceptions for caregivers and home-bound patients).
• No public consumption. Smoking flower in public — including on private outdoor spaces visible to the public — can draw a citation under municipal ordinances and the state's smoke-free laws.
• No employer protection beyond the narrow Act 491 (2022) carve-outs for state and local government employees in non-safety-sensitive roles.
• No out-of-state reciprocity. Louisiana does not honor any other state's medical card. See reciprocity.

What Makes Louisiana's Program "Most Medical"

• Licensed by the Louisiana Board of Pharmacy — the same regulator that licenses every other Louisiana pharmacy.
• Dispensed by a pharmacist-in-charge with full pharmacy-credentialing requirements.
• Counseling on dosing, drug interactions, and onset times is part of the dispense.
• Integrated with Louisiana's broader prescription-monitoring infrastructure.
• Production limited to two land-grant universities — a structural integration with public-research institutions.

Critique of the Program

Critics — would-be Louisiana cannabis operators, NORML, and a handful of legislators — argue:

• 10 pharmacies for 4.55 million people means most patients drive 30 to 90 minutes for each refill.
• Louisiana flower retails at $45–$60 per eighth — significantly higher than Mississippi's ~$25–$40 or Arkansas's $35–$50.
• The university monopoly stifles competition and concentrates economic benefits in two institutions.
• Bills to expand the producer count have been introduced in nearly every session since 2019; nearly all die in committee.

Official Sources

• Louisiana Department of Health — Medical Marijuana Program
• Louisiana Board of Pharmacy
• Louisiana State Legislature — LRS §40:1046 full text